Mitsubishi Tanabe Pharma <4508.T>-2008/09 group

May 8 (Reuters) -

MITSUBISHI TANABE PHARMA CORP

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to Six months to

Mar 31, 2009 Mar 31, 2008 Mar 31, 2010 Sep 30, 2009

LATEST YEAR-AGO COMPANY COMPANY

RESULTS RESULTS FORECASTS H1 FORECASTS
Sales 414.75 315.64 408.00 199.50

(-1.6%) (-3.3%)
Operating 71.69 54.02 63.50 22.50

(-11.4%) (-34.0%)
Recurring 72.58 54.41 63.50 22.50

(-12.5%) (-36.0%)
Net 26.53 21.99 32.50 10.00

(+22.5%) (-39.0%)
EPS Y47.28 Y50.12 Y57.91 Y17.82
Annual div Y28.00 Y20.68 Y28.00
-Q2 div Y14.00 Y14.00
-Q4 div Y14.00 Y13.00 Y14.00

NOTE - Mitsubishi Tanabe Pharma Corp is a leading drug maker with strength in drugs
for circulatory system.

For latest earnings estimates made by Toyo Keizai, please
double click on 4508.TK1.